Benzoic Acid

Benzoic Acid

SCHEMBL6534685

O=C(NC(C(=O)O)c1ccccc1)c1ccccc1.O=C(O)c1ccccc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.63
CA2 P00918 2/20 0.63
LMNA P02545 2/20 0.53
HPGD P15428 1/20 0.53
CTRB1 P17538 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TSHR P16473 2/20 0.50
S1PR4 O95977 2/20 0.50
S1PR3 Q99500 2/20 0.50
ALDH1A1 P00352 2/20 0.50
DAO P14920 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10102772 0.94 CA1 (0.69) CA1CA2LMNAHPGDCTRB1
SCHEMBL18232126 0.94 CA1 (0.69) CA1CA2LMNAHPGDCTRB1
SCHEMBL1649573 0.94 CA1 (0.69) CA1CA2LMNAHPGDCTRB1
SCHEMBL28419504 0.88 CA1 (0.57) CA1CA2LMNAHPGDSMN1; SMN2
SCHEMBL6380018 0.84 CA1 (0.57) CA1CA2LMNAHPGDCTRB1
SCHEMBL6380009 0.84 CA1 (0.57) CA1CA2LMNAHPGDCTRB1
SCHEMBL4677603 0.83 CA1 (0.64) CA1CA2LMNAHPGDSMN1; SMN2
SCHEMBL14595547 0.81 LMNA (0.56) CA1CA2LMNAHPGDCTRB1
SCHEMBL6963259 0.81 LMNA (0.56) CA1CA2LMNAHPGDCTRB1
SCHEMBL9848833 0.80 ALDH1A1 (0.55) CA1CA2LMNAHPGDCTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888458-A4 COMBINATIONS OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCERS SLOAN KETTERING INSTITUTEFOR C (US) 2004-05-06 EP disclosed
EP-0888458-A1 COMBINATIONS OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCERS Sloan-Kettering Institute For Cancer Research (US) 1999-01-07 EP disclosed
WO-1997030174-A1 COMBINATIONS OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCERS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1997-08-21 WO disclosed